RBFOX2 and acute myeloid leukemia: Overexpressed RBFOX2 inhibits the expression of TGFB1 through the RBFOX2/m6A/RBM15/YTHDC1/PRC2 axis, blocks the transforming growth factor‐beta (TGF‐β) signalling pathway, and promotes the progression of AML.